Page last updated: 2024-10-18

dihydroxyphenylalanine and Trigeminal Neuralgia

dihydroxyphenylalanine has been researched along with Trigeminal Neuralgia in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gladkova, EP1
Matlina, ESh1

Other Studies

1 other study available for dihydroxyphenylalanine and Trigeminal Neuralgia

ArticleYear
[The state of the sympathetic-adrenal system during treatment of trigeminal nerve neuralgia].
    Klinicheskaia meditsina, 1971, Volume: 49, Issue:7

    Topics: Adrenal Glands; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Humans; Male; Mi

1971